323 related articles for article (PubMed ID: 17079165)
21. On-column refolding of recombinant human interleukin-4 from inclusion bodies.
Razeghifard MR
Protein Expr Purif; 2004 Sep; 37(1):180-6. PubMed ID: 15294296
[TBL] [Abstract][Full Text] [Related]
22. Expression, refolding, and activity of a recombinant nonhemorrhagic snake venom metalloprotease.
Selistre-de-Araujo HS; de Souza EL; Beltramini LM; Ownby CL; Souza DH
Protein Expr Purif; 2000 Jun; 19(1):41-7. PubMed ID: 10833388
[TBL] [Abstract][Full Text] [Related]
23. [Expression and purification of recombinant Trail protein in E.coli and the optimal conditions for Trail purification].
Cai YY; Li XY; Wu Y; DU JC; Xu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jun; 28(6):596-600. PubMed ID: 22691351
[TBL] [Abstract][Full Text] [Related]
24. Expression, refolding and purification of a human interleukin-17A variant.
Wu B; Nemeth JF; Janecki DJ; Jones B; Obmolova G; Malia TJ; Baker A; Bethea D; Elloso MM; Naso M; Taudte S
Cytokine; 2011 Jan; 53(1):107-14. PubMed ID: 20674388
[TBL] [Abstract][Full Text] [Related]
25. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli.
Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102
[TBL] [Abstract][Full Text] [Related]
26. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli.
Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889
[TBL] [Abstract][Full Text] [Related]
27. Recombinant human epidermal growth factor inclusion body solubilization and refolding at large scale using expanded-bed adsorption chromatography from Escherichia coli.
Sharma K; Babu PV; Sasidhar P; Srinivas VK; Mohan VK; Krishna E
Protein Expr Purif; 2008 Jul; 60(1):7-14. PubMed ID: 18430585
[TBL] [Abstract][Full Text] [Related]
28. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
Vallejo LF; Rinas U
Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
[TBL] [Abstract][Full Text] [Related]
29. Fed-batch production of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in soluble form in Escherichia coli and its purification and characterization.
Li P; Gu Q; Wu X
Protein Expr Purif; 2016 Oct; 126():115-121. PubMed ID: 27335160
[TBL] [Abstract][Full Text] [Related]
30. [Adeno-associated virus mediated tumor necrosis factor related apoptosis inducing ligand gene transfected into hepatocellular carcinoma cells by ultrasound microbubble intensifier: an experimental study].
Xia JT; Xu B; Wang SC; Lai YY; Wu ZF; Li SH; Li W
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1846-50. PubMed ID: 19040022
[TBL] [Abstract][Full Text] [Related]
31. L-cysteine-enhanced renaturation of bioactive soluble tumor necrosis factor ligand family member LIGHT from inclusion bodies in Escherichia coli.
Tsuji I; Mastui H; Ito T; Kurokawa T; Shintani Y
Protein Expr Purif; 2011 Dec; 80(2):239-45. PubMed ID: 21745574
[TBL] [Abstract][Full Text] [Related]
32. Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients.
Tanaka H; Ito T; Kyo T; Kimura A
Eur J Haematol; 2007 May; 78(5):389-98. PubMed ID: 17432976
[TBL] [Abstract][Full Text] [Related]
33. Construction, expression, and purification of HIV-TAT-survivin (T34A) mutant: a pro-apoptosis protein in Escherichia coli.
Ma X; Zheng W; Wei D; Ma Y; Wang T; Wang J; Liu Q; Yang S
Protein Expr Purif; 2006 May; 47(1):36-44. PubMed ID: 16260148
[TBL] [Abstract][Full Text] [Related]
34. TRAIL in the mandarin fish Siniperca chuatsi: gene and its apoptotic effect in HeLa cells.
Gao Y; Chang MX; Sun BJ; Nie P
Fish Shellfish Immunol; 2008 Jan; 24(1):55-66. PubMed ID: 18083044
[TBL] [Abstract][Full Text] [Related]
35. Refolding and purification of rhNTA protein by chromatography.
Fan X; Xu D; Lu B; Xia J; Wei D
Biomed Chromatogr; 2009 Mar; 23(3):257-66. PubMed ID: 19101913
[TBL] [Abstract][Full Text] [Related]
36. One-step on-column purification and refolding of a single-chain variable fragment (scFv) antibody against tumour necrosis factor alpha.
Liu M; Wang X; Yin C; Zhang Z; Lin Q; Zhen Y; Huang H
Biotechnol Appl Biochem; 2006 Mar; 43(Pt 3):137-45. PubMed ID: 16293104
[TBL] [Abstract][Full Text] [Related]
37. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
[TBL] [Abstract][Full Text] [Related]
38. Expression of a kallikrein-like protease from the snake venom: engineering of autocatalytic site in the fusion protein to facilitate protein refolding.
Hung CC; Chiou SH
Biochem Biophys Res Commun; 2000 Sep; 275(3):924-30. PubMed ID: 10973823
[TBL] [Abstract][Full Text] [Related]
39. On-column refolding and purification of recombinant human interleukin-1 receptor antagonist (rHuIL-1ra) expressed as inclusion body in Escherichia coli.
Tan H; Dan G; Gong H; Cao L
Biotechnol Lett; 2005 Aug; 27(16):1177-82. PubMed ID: 16158260
[TBL] [Abstract][Full Text] [Related]
40. [Using process of refolding the protein to obtain recombinant human interleukin-1 receptor antagonist].
Li S; Deng X; Zhao H; Huang X; Yu T; Cheng Y; Dan G
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Oct; 24(5):1128-32. PubMed ID: 18027711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
